LONDON, March 12 (Reuters) - Schering-Plough (SGP.N: Quote, Profile , Research) will cut some jobs after acquiring Akzo Nobel's (AKZO.AS: Quote, Profile , Research) drugs unit, Organon BioSciences, but staff reductions will be limited, the chief executive of the U.S. group said on Monday.
